Hospital Sírio-Libanês
Hospital Sírio-Libanês scored 75/100 on Panya's 11-signal vendor rubric. Each signal is scored 0 to 100, the methodology is public, and our affiliate posture is flat-fee — never pay-to-rank. Below is the full per-signal breakdown.
- COA on every lot90
- Cold-chain verifiedJCI 2007 + JCI Primary Care 2024 (only in Brazil)90
- Rx legality (ANVISA)ANVISA retained-Rx for all GLP-1s95
- Compound identityNewsweek Brazil #2 (7th consecutive year)90
- Dose accuracyObesidade & Cirurgia Bariátrica center, named team90
- Endotoxin testing80
- Refund posture65
- Channel clarityBela Vista (SP) flagship + Brasília85
- Support qualityPT/EN, intl-patient ops85
- Price transparencyby consult; premium tier55
- Longitudinal retentionObesity & Eating Disorders Center coordinated75
ANVISA-approved Oct 2023; pharmacy availability since May 2025. Drogasil / Drogaria São Paulo / Pague Menos. Hospital prescription required (ANVISA retained-Rx mandate).
Established T2D + off-label weight. Cheaper than Wegovy. Drogasil / Pague Menos retail.
ANVISA-approved Jan 2023 — Brazil was one of the first ex-US Wegovy markets. Premium hospital channel mature.
The 11-signal rubric is public.
Identity, dose accuracy, COA, cold-chain, Rx legality, compound identity, endotoxin testing, refund posture, channel clarity, support quality, price transparency, longitudinal retention. Each scored 0 to 100. Vendors that fail our floor are silently filtered out — they don't appear in our match flow at all.
If Hospital Sírio-Libanês wants to dispute or update this score, contact partner@panya.health. Score updates are recorded on this page with a public changelog.
Want a match for your situation?
Take the 2-minute quiz. We'll match you against this and the other vendors in your region — based on your dose, urgency, and budget.
We earn a small commission when you buy through recommended vendors. That is how this stays free. Vendors rank by quality signals, not paid placement.